Par Pharmaceutical to Acquire Second Generics Company of 2011
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 9 (Table of Contents)
Published: 1 Sep-2011
DOI: 10.3833/pdr.v2011.i9.1528 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Par Pharmaceutical has agreed to buy privately held Anchen Pharmaceuticals for US$410 M in order to expand its generic drugs portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018